Cargando…

A new visual quantitative assessment of ultrasound attenuation parameters for the mild liver steatosis

BACKGROUND: Controlled attenuation parameter (CAP) without the guidance of the grey scale sonogram was a classic method in the quantitative evaluation of liver steatosis, it is recommended by international guidelines. Our study aimed to compare the diagnostic efficiency of a new real-time visual liv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Xinping, Wang, Junqing, Xia, Shujun, Zhan, Weiwei, Li, Ruokun, Chen, Zhijie, Tian, Jingyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011258/ https://www.ncbi.nlm.nih.gov/pubmed/35433934 http://dx.doi.org/10.21037/atm-22-989

Ejemplares similares

Quantitative assessment of liver steatosis using ultrasound controlled attenuation parameter (Echosens)
por: Ferraioli, Giovanna
Publicado: (2021)

Noninvasive Assessment of Liver Fibrosis and Inflammation in Chronic Hepatitis B: A Dual-task Convolutional Neural Network (DtCNN) Model Based on Ultrasound Shear Wave Elastography
por: Wang, Chengyan, et al.
Publicado: (2022)

Quantitative ultrasound radiofrequency data analysis for the assessment of hepatic steatosis using the controlled attenuation parameter as a reference standard
por: Jeon, Sun Kyung, et al.
Publicado: (2021)

Reproducibility of ultrasound-guided attenuation parameter (UGAP) to the noninvasive evaluation of hepatic steatosis
por: Zhao, Yanan, et al.
Publicado: (2022)

Tissue attenuation imaging and tissue scatter imaging for quantitative ultrasound evaluation of hepatic steatosis
por: Rónaszéki, Aladár D., et al.
Publicado: (2022)

Accuracy of controlled attenuation parameter compared with ultrasound for detecting hepatic steatosis in children with severe obesity
por: Runge, Jurgen H., et al.
Publicado: (2020)

Comparing the controlled attenuation parameter using FibroScan and attenuation imaging with ultrasound as a novel measurement for liver steatosis
por: Hsu, Po-Ke, et al.
Publicado: (2021)

The ultrasound‐guided attenuation parameter is useful in quantification of hepatic steatosis in non‐alcoholic fatty liver disease
por: Ogino, Yu, et al.
Publicado: (2021)

Retraction: Comparing the controlled attenuation parameter using FibroScan and attenuation imaging with ultrasound as a novel measurement for liver steatosis
Publicado: (2022)

Reproducibility of ultrasound attenuation imaging for the noninvasive evaluation of hepatic steatosis
por: Yoo, Jeongin, et al.
Publicado: (2020)

Feasibility of Ultrasound Attenuation Imaging for Assessing Pediatric Hepatic Steatosis
por: Song, Kyungchul, et al.
Publicado: (2022)

Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease
por: Ahn, Jem Ma, et al.
Publicado: (2016)

How many times should we repeat measurements of the ultrasound-guided attenuation parameter for evaluating hepatic steatosis?
por: Seo, Duck Min, et al.
Publicado: (2023)

The diagnostic value of novel ultrasound attenuation analysis in detecting liver steatosis identified by the controlled attenuation parameter: a diagnostic accuracy study
por: Jiang, Meijuan, et al.
Publicado: (2023)

Development and validation of multivariable quantitative ultrasound for diagnosing hepatic steatosis
por: Jeon, Sun Kyung, et al.
Publicado: (2023)

Accuracy of attenuation imaging in the assessment of pediatric hepatic steatosis: correlation with the controlled attenuation parameter
por: Kim, Pyeong Hwa, et al.
Publicado: (2022)

Diagnostic Accuracy of Non-Imaging and Ultrasound-Based Assessment of Hepatic Steatosis Using Controlled Attenuation Parameter (CAP) as Reference
por: Kozłowska-Petriczko, Katarzyna, et al.
Publicado: (2021)

Attenuation Imaging with Ultrasound as a Novel Evaluation Method for Liver Steatosis
por: Hsu, Po-Ke, et al.
Publicado: (2021)

Relationship Between Greyscale Ultrasound Grading of Hepatic Steatosis and Attenuation Imaging
por: Rehman, Abdur, et al.
Publicado: (2022)

Controlled Attenuation Parameter for Quantification of Steatosis: Which Cut-Offs to Use?
por: Sirli, Roxana, et al.
Publicado: (2021)

Usefulness of the Controlled Attenuation Parameter for Detecting Liver Steatosis in Health Checkup Examinees
por: Kim, Ja Kyung, et al.
Publicado: (2015)

The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter
por: Lee, Hye Won, et al.
Publicado: (2017)

Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter
por: Ferraioli, Giovanna, et al.
Publicado: (2017)

Validating controlled attenuation parameter in the assessment of hepatic steatosis in living liver donors
por: Broering, Dieter, et al.
Publicado: (2021)

Accuracy of controlled attenuation parameter measurement for the detection of steatosis in autoimmune liver diseases
por: Steinmann, Silja, et al.
Publicado: (2023)

Eradication of hepatitis C virus is associated with the attenuation of steatosis as evaluated using a controlled attenuation parameter
por: Shimizu, Kohei, et al.
Publicado: (2018)

Effects of Different Scan Projections on the Quantitative Ultrasound-Based Evaluation of Hepatic Steatosis
por: De Rosa, Laura, et al.
Publicado: (2022)

Quantitative Evaluation of Hepatic Steatosis Using Advanced Imaging Techniques: Focusing on New Quantitative Ultrasound Techniques
por: Park, Junghoan, et al.
Publicado: (2022)

Simultaneous imaging of ultrasonic relative backscatter and attenuation coefficients for quantitative liver steatosis assessment
por: Timaná, José, et al.
Publicado: (2023)

Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases
por: Ni, Xi-Xi, et al.
Publicado: (2021)

Controlled attenuation parameters to assess liver steatosis in obese patients with polycystic ovary syndrome
por: Wang, Dongxu, et al.
Publicado: (2023)

Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study
por: Yoo, Jeong-Ju, et al.
Publicado: (2020)

Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease
por: Pirmoazen, Amir M., et al.
Publicado: (2020)

Association of hepatic steatosis derived from ultrasound and quantitative MRI with prediabetes in the general population
por: Naeem, Muhammad, et al.
Publicado: (2021)

Ultrasound-Guided Fine-Needle Aspiration Versus Fine-Needle Capillary Sampling in Evaluation of Lymph Node Metastasis of Thyroid Cancer
por: Xia, Shujun, et al.
Publicado: (2021)

New diagnostic technique to evaluate hepatic steatosis using the attenuation coefficient on ultrasound B mode
por: Koizumi, Yohei, et al.
Publicado: (2019)

Diagnostic Performance of FibroTouch Ultrasound Attenuation Parameter and Liver Stiffness Measurement in Assessing Hepatic Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
por: Qu, Ying, et al.
Publicado: (2021)

Quantitative ultrasound, elastography, and machine learning for assessment of steatosis, inflammation, and fibrosis in chronic liver disease
por: Destrempes, François, et al.
Publicado: (2022)

Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements
por: Mikolasevic, Ivana, et al.
Publicado: (2021)

Evaluation of Microwave Ablation in 4T1 Breast Tumor by a Novel VEFGR2 Targeted Ultrasound Contrast Agents
por: Li, Xiaoyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o7ic3o5rr3jgvd7ste4eu9uni6